Cite

HARVARD Citation

    Dage, J. et al. (n.d.). P4‐127: Exploring the Utility of CSF Neurogranin Levels in An Alzheimer's Disease Clinical Trial. Alzheimer's & dementia. p. P1062. [Online]. 
  
Back to record